Premium
Antiinflammatory Effects of Ginger and Some of its Components in Human Bronchial Epithelial (BEAS‐2B) Cells
Author(s) -
Podlogar Julia A.,
Verspohl Eugen J.
Publication year - 2012
Publication title -
phytotherapy research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.019
H-Index - 129
eISSN - 1099-1573
pISSN - 0951-418X
DOI - 10.1002/ptr.3558
Subject(s) - proinflammatory cytokine , zingiber officinale , lipopolysaccharide , chemokine , rhizome , pharmacology , zingiberaceae , chemistry , secretion , metabolite , traditional medicine , interleukin , biology , cytokine , biochemistry , medicine , immunology , inflammation
The proinflammatory chemokine interleukin‐8 is increased in asthmatic patients. Traditionally, ginger is used as an antiinflammatory drug. An extract and several compounds of Zingiber officinale (ginger) were tested in human bronchial epithelial cells (BEAS‐2B cells) with respect to their effect on lipopolysaccharide (LPS)‐induced secretion of the proinflammatory chemokine interleukin 8 (IL‐8) and RANTES (regulated upon activation, normal T‐cell expressed and secreted). An oily extract of ginger rhizome with > 25% total pungent compounds, ginger volatile oil, ar ‐curcumene and α‐pinene reduced the LPS‐induced IL‐8 secretion (measured by a specific enzyme‐linked immunosorbent assay), whereas a spissum extract, the pungents [6]‐gingerol and its metabolite [6]‐shogaol, and the terpenoids citral and β‐phellandrene showed no effect. The LPS‐induced slight increase of RANTES was reduced by volatile oil, ar ‐curcumene and α‐pinene. There was no effect of LPS on TNF‐α. Our results suggest that distinct ginger compounds could be used as antiinflammatory drugs in respiratory infections. Copyright © 2011 John Wiley & Sons, Ltd.